Aimovig™ Receives FDA Approval for Migraine Prevention
2018-05-17
It's a big day for people living with Migraine disease. For the first time in history, we have a treatment that was specifically developed to prevent Migraine attacks. Aimovig™ (erenumab-aooe) received FDA approval for the prevention of Migraine in patients experiencing four or more Migraine days per month. Read More →